Pharmacological characterization of I1 and I2 imidazoline receptors in human striatum

Neurochemistry International

Volumn 30, Issue 1, 1997, Pages 25-29

  Flamez, Anja ^a   De Backer, Jean Paul ^a   Czerwiec, Eva ^a   Ladure, Philippe ^b   Vauquelin, Georges ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 BENZOFURANYL) 2 IMIDAZOLINE; 2 (2 IMIDAZOLIN 2 YL)QUINOLINE; 2 (2 IMIDAZOLIN 2 YL)QUINOXALINE; ALPHA 2 ADRENERGIC RECEPTOR; BENZODIOXAN DERIVATIVE; CIRAZOLINE; CLONIDINE; EFAROXAN; IDAZOXAN; IMIDAZOLINE RECEPTOR; UNCLASSIFIED DRUG; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2-METHOXYIDAZOXAN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; DRUG RECEPTOR; IMIDAZOLINE RECEPTORS;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR AFFINITY; STEREOCHEMISTRY; ALLOSTERISM; METABOLISM; MIDDLE AGED; STRUCTURE ACTIVITY RELATION;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; ALLOSTERIC REGULATION; CLONIDINE; CORPUS STRIATUM; FEMALE; HUMANS; IDAZOXAN; MALE; MIDDLE AGED; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030614875     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00040-X     Document Type: Article

References (17)

1. 3H]idazoxan binding sites (NAIBS) in postmortem brains of suicide victims. Fundam. Clin. Pharmacol. 6(57s), 27.
2. Bousquet, P., Feldman, J. and Schwartz, J. (1984) Central cardiovascular effects of α-adrenergic drugs: difference between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230, 232-236.
3. 2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol Exp. Ther. 245, 600-607.
4. 2-adrenergic receptors and non-stereoselective sites in human and rabbit cortex membranes. Biochem. Pharmacol. 38, 455-463.
5. Coupry, I., Podevin, R. A., Dausse, J.-P. and Parini, A. (1987) Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem. Biophys. Res. Comm. 147, 1055-1060.
6. 2-adrenoceptors in the human central nervous system. Neuroscience 59, 589-598.
7. 2-adrenoceptor antagonist in human frontal cortex membranes. Neurochem. Int. 18, 137-140.
8. 2 subtypes. Fundam. Clin. Pharmacol. 6(55s), 18.
9. Hamilton, C. A., Yakubu, M. A., Jardine, E. and Reid, J. L. (1991) Imidazole binding sites in rabbit kidney and forebrain membranes. J. Auton. Pharmacol. 11, 277-283.
10. 2-sites). Br. J. Pharmacol. 112(320P), (1994.
11. 2A-adrenoceptors. Eur. J. Pharmacol. 167, 95-104.
12. 2-adrenergic drugs also bind with high affinity to a non adrenergic site. Mol. Pharmacol. 35, 324-330.
13. Michel, M. C. and Insel, P. (1989) Are there multiple imidazoline binding sites? TIPS 10, 342-344.
14. Nahorski, S. R., Barnett, D. B. and Cheung, Y. D. (1985) α-Adrenoceptor-effector coupling: affinity states or heterogeneity of the α-adrenoceptor? Clin. Sci. 68, 39s-42s.
15. 2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease. Neurosci. Lett. 160, 109-112.
16. 3H]idazoxan. Neurochem. Int. 17, 537-546.
17. Vigne, P., Lazdunski, M. and Frelin, C. (1989) Guanabenz, guanochlor, guanoxan and idazoxan bind with high affinity to non-adrenergic sites in pig kidney membranes. Eur. J. Pharmacol. 160, 295-298.